Quinelorane (dihydrochloride)
Product Specifications
UNSPSC Description
Quinelorane dihydrochloride (LY163502) is a potent dopamine D3/D2 receptor agonist. Quinelorane has the potential for neurological and psychiatric disorders research[1][2].
Target Antigen
Dopamine Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein;Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/quinelorane-dihydrochloride.html
Purity
99.0
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
NC1=NC=C2C[C@]3([H])[C@@](CCCN3CCC)([H])CC2=N1.[H]Cl.[H]Cl
Molecular Weight
319.27
References & Citations
[1]Ying Qu, et al. Quinelorane, a dopamine D3/D2 receptor agonist, reduces prepulse inhibition of startle and ventral pallidal GABA efflux: time course studies. Pharmacol Biochem Behav. 2008 Oct;90(4):686-90.|[2]Morgane Thomsen, et al. Psychomotor stimulation by dopamine D₁-like but not D₂-like agonists in most mouse strains. Exp Clin Psychopharmacol. 2011 Oct;19(5):342-60.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-103429/Quinelorane-dihydrochloride-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-103429/Quinelorane-dihydrochloride-SDS-MedChemExpress.pdf
Clinical Information
Phase 3
CAS Number
97548-97-5
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![PD1 (PDCD1) Mouse Monoclonal Antibody [Clone ID: OTI17F7]](https://cdn.genprice.uk/products/937/68dd18b9061270361e908211/imageurl/cf807988.webp)
MBS6312019-01 0.2 mL
Kallikrein 6, NT (KLK6, PRSS18, PRSS9, Kallikrein-6, Neurosin, Protease M, SP59, Serine protease 18, Serine protease 9, Zyme) (FITC)
Ask
View Details MBS6312019-02 5x 0.2 mL
Kallikrein 6, NT (KLK6, PRSS18, PRSS9, Kallikrein-6, Neurosin, Protease M, SP59, Serine protease 18, Serine protease 9, Zyme) (FITC)
Ask
View Details 
